Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Prostate Cancer”

1,461 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,461 results

Testing effectiveness (Phase 2)Study completedNCT00214097
What this trial is testing

Phase I/II Hypofractionated Radiotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 347
Not applicableLooking for participantsNCT04945642
What this trial is testing

High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIC Prostate Cancer AJCC v8+5 more
Jonsson Comprehensive Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT00589420
What this trial is testing

Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 18
Very early researchStudy completedNCT01434342
What this trial is testing

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Who this might be right for
Lung CancerTobacco Use DisorderBreast Cancer+2 more
Wake Forest University Health Sciences 146
Not applicableLooking for participantsNCT06325046
What this trial is testing

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Who this might be right for
Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Mayo Clinic 144
Testing effectiveness (Phase 2)Looking for participantsNCT04989946
What this trial is testing

Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 60
Testing effectiveness (Phase 2)Study completedNCT01485861
What this trial is testing

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Who this might be right for
Prostate Cancer
Genentech, Inc. 298
Testing effectiveness (Phase 2)Ended earlyNCT00176631
What this trial is testing

Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 10
Testing effectiveness (Phase 2)Ended earlyNCT01913197
What this trial is testing

Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy

Who this might be right for
Prostate Cancer
St. Luke's-Roosevelt Hospital Center 2
Testing effectiveness (Phase 2)Looking for participantsNCT06568094
What this trial is testing

HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07218666
What this trial is testing

Zanzalintinib in Men With Aggressive Variant Prostate Cancer

Who this might be right for
Aggressive Variant Prostate Carcinoma
Deepak Kilari 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592237
What this trial is testing

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT00589472
What this trial is testing

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00148772
What this trial is testing

Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy

Who this might be right for
Prostate Cancer
Endeavor Health 29
Testing effectiveness (Phase 2)Looking for participantsNCT06568562
What this trial is testing

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Utah 32
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Testing effectiveness (Phase 2)Study completedNCT01902680
What this trial is testing

Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.

Who this might be right for
Localized Prostate Cancer
Institut Claudius Regaud 18
Testing effectiveness (Phase 2)Ended earlyNCT02946996
What this trial is testing

Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
Medical University of South Carolina 41
Testing effectiveness (Phase 2)UnknownNCT00218205
What this trial is testing

Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Department of Veterans Affairs, New Jersey 28
Testing effectiveness (Phase 2)Looking for participantsNCT05790213
What this trial is testing

Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation

Who this might be right for
Prostate Cancer
University of Chicago 57
Load More Results